We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Prolactin Assay Released for Fully Automated Immunoassay System

By Labmedica staff writers
Posted on 03 Jun 2008
Print article
A prolactin assay designed for use with a fully automated immunoassay system was recently introduced for sale in the United States.

The prolactin assay is a two-step immunometric assay with a very broad measuring range of approximately 0.05-300 µg/l. It measures quantitative concentrations of prolactin in either 50 µl of serum or lithium-heparin plasma samples after 28 minutes of processing time. Each prolactin kit is sufficient to process 100 tests, and contains prolactin reagents, a single ready-to-use calibrator, and a single ready-to-use control. Reagents are stable for 28 days on board the immunoassay system.

Developed by Olympus (Center Valley, PA, USA) for the AU3000i immunoassay system, the prolactin assay is a paramagnetic particle (DynaBeads) chemiluminescent immunoassay for the in vitro quantitative measurement of prolactin in human serum or lithium-heparin plasma.

The main physiologic function of prolactin, a fertility hormone, is to promote female breast development and to initiate and maintain lactation. Measurement of prolactin is one of the most commonly undertaken hormonal investigations in evaluating patients with reproductive disorders. Prolactin levels are also determined when breast cancer and pituitary tumors are suspected. Abnormally high levels of prolactin are associated with female infertility, impotence, and infertility in men, primary hypothyroidism, and pituitary tumors. Determination of prolactin concentrations can also be useful in the diagnosis and treatment of hypothalamic-pituitary disorders.

Olympus serves healthcare and commercial laboratory markets with integrated product solutions and financial, educational, and consulting services that help customers to achieve reliable results more efficiently. Olympus develops technologies and new product designs. These include: gastrointestinal endoscopes, accessories, and minimally invasive surgical products; advanced clinical and research microscopes; and lab automation systems, blood bank and chemistry-immuno analyzers, and reagents.


Related Links:
Olympus
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Alpha-1-Antitrypsin ELISA
IDK alpha-1-Antitrypsin ELISA
New
Toxoplasma Gondii Test
Toxo IgG ELISA Kit

Print article

Channels

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.